Saama was selected as a CARE Awards finalist in recognition of the company’s development and 2018 introduction of the virtual assistant DaLIA (Deep Learning Intelligent Assistant). DaLIA is a unique set of Artificial Intelligence (AI) capabilities specifically designed to alleviate the planning, feasibility and conduct challenges inherent in and pervasive throughout the drug development continuum.
“Saama is thrilled to be recognized as a 2019 CARE Awards finalist for DaLIA’s ability to accelerate life science industry business outcomes and drive therapeutic innovation,” said Amit Gulwadi, Senior Vice President of Clinical Innovations at Saama. “DaLIA embodies Saama’s commitment to advancing outcomes-based AI to strategically interact with trial data.”
DaLIA harnesses Natural Language Processing (NLP) and Natural Language Understanding (NLU) to provide easy-to-use, context and domain-aware conversational experiences with key Clinical Trial data and insights from Saama’s award-winning Life Science Analytics Cloud (LSAC). DaLIA facilitates an unprecedented conversational experience with clinical trial data that overcomes obstacles historically associated with clinical development, and improves the life sciences industry’s ability to deliver safe and effective therapies.
The CARE Awards 2019 feature 11 categories, which showcase significant accomplishments and highlight innovation across the industry – from rare disease drug development and patient centricity in trials and research, to product and technological development, clinical results and collaborative efforts between individuals, departments, or companies. Entries are judged independently by a panel of experts from all core sectors of the clinical R&D industry. The full list of 2019 CARE Awards finalists is available here.
The 2019 winners will be announced at a ceremony on Thursday, 2 May at the Hyatt Regency Boston, MA, where distinguished leaders in the biopharmaceutical, CRO, and diagnostic industries from all corners of the globe will gather.
About Informa Pharma Intelligence
Informa Pharma Intelligence powers a full suite of analysis products – Datamonitor Healthcare, Sitetrove, Trialtrove, Pharmaprojects, Medtrack, Biomedtracker, Scrip, Pink Sheet and In Vivo – to deliver the data needed by the pharmaceutical and biomedical industry to make decisions and create real-world opportunities for growth.
With more than 500 analysts keeping their fingers on the pulse of the industry, no key disease, clinical trial, drug approval or R&D project isn’t covered through the breadth and depth of data available to customers. For more information visit pharmaintelligence.informa.com.
Saama Technologies is the advanced clinical data and analytics company, unleashing wisdom from data to deliver better business outcomes for the life sciences industry. Saama’s unified, AI-driven clinical data analytics platform seamlessly integrates, curates, and animates unlimited sources of structured, unstructured, and real-world data to deliver actionable insights across all therapeutic areas. The award-winning platform gives unprecedented real-time visibility into clinical data, enabling sponsors to file New Drug Applications (NDAs) more efficiently to bring drugs to market faster and at lower costs. For more information, visit http://www.saama.com.
The post Saama Announced as a Finalist in Clinical Trial Process Innovation Category for 2019 Clinical & Research Excellence Awards appeared first on Saama Technologies.
This post first appeared on Saama Technologies Inc, please read the originial post: here